These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36507847)

  • 1. The Effects of the Dopamine Transporter Ligands JJC8-088 and JJC8-091 on Cocaine versus Food Choice in Rhesus Monkeys.
    Rahimi O; Cao J; Lam J; Childers SR; Rais R; Porrino LJ; Newman AH; Nader MA
    J Pharmacol Exp Ther; 2023 Mar; 384(3):372-381. PubMed ID: 36507847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic.
    Zhang HY; Bi GH; Yang HJ; He Y; Xue G; Cao J; Tanda G; Gardner EL; Newman AH; Xi ZX
    Neuropsychopharmacology; 2017 Aug; 42(9):1871-1883. PubMed ID: 28266501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical dopamine transporter inhibitors attenuate compulsive-like methamphetamine self-administration in rats.
    Tunstall BJ; Ho CP; Cao J; Vendruscolo JCM; Schmeichel BE; Slack RD; Tanda G; Gadiano AJ; Rais R; Slusher BS; Koob GF; Newman AH; Vendruscolo LF
    Neuropharmacology; 2018 Mar; 131():96-103. PubMed ID: 29217282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disorders.
    Newman AH; Cao J; Keighron JD; Jordan CJ; Bi GH; Liang Y; Abramyan AM; Avelar AJ; Tschumi CW; Beckstead MJ; Shi L; Tanda G; Xi ZX
    Neuropsychopharmacology; 2019 Jul; 44(8):1435-1444. PubMed ID: 30858517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reduced rate of in vivo dopamine transporter binding is associated with lower relative reinforcing efficacy of stimulants.
    Wee S; Carroll FI; Woolverton WL
    Neuropsychopharmacology; 2006 Feb; 31(2):351-62. PubMed ID: 15957006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential therapeutics for effort-related motivational dysfunction: assessing novel atypical dopamine transport inhibitors.
    Ecevitoglu A; Meka N; Rotolo RA; Edelstein GA; Srinath S; Beard KR; Carratala-Ros C; Presby RE; Cao J; Okorom A; Newman AH; Correa M; Salamone JD
    Neuropsychopharmacology; 2024 Jul; 49(8):1309-1317. PubMed ID: 38429498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys.
    Wilcox KM; Lindsey KP; Votaw JR; Goodman MM; Martarello L; Carroll FI; Howell LL
    Synapse; 2002 Jan; 43(1):78-85. PubMed ID: 11746736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo comparison of the reinforcing and dopamine transporter effects of local anesthetics in rhesus monkeys.
    Wilcox KM; Kimmel HL; Lindsey KP; Votaw JR; Goodman MM; Howell LL
    Synapse; 2005 Dec; 58(4):220-8. PubMed ID: 16206183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys.
    Letchworth SR; Nader MA; Smith HR; Friedman DP; Porrino LJ
    J Neurosci; 2001 Apr; 21(8):2799-807. PubMed ID: 11306632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging.
    Lindsey KP; Wilcox KM; Votaw JR; Goodman MM; Plisson C; Carroll FI; Rice KC; Howell LL
    J Pharmacol Exp Ther; 2004 Jun; 309(3):959-69. PubMed ID: 14982963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response and duration effects of acute administrations of cocaine and GBR12909 on dopamine synthesis and transporter in the conscious monkey brain: PET studies combined with microdialysis.
    Tsukada H; Harada N; Nishiyama S; Ohba H; Kakiuchi T
    Brain Res; 2000 Mar; 860(1-2):141-8. PubMed ID: 10727633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reinforcing efficacy of psychostimulants in rhesus monkeys: the role of pharmacokinetics and pharmacodynamics.
    Lile JA; Wang Z; Woolverton WL; France JE; Gregg TC; Davies HM; Nader MA
    J Pharmacol Exp Ther; 2003 Oct; 307(1):356-66. PubMed ID: 12954808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ( R)-Modafinil and Modafinil Analogues on Dopamine Dynamics Assessed by Voltammetry and Microdialysis in the Mouse Nucleus Accumbens Shell.
    Keighron JD; Quarterman JC; Cao J; DeMarco EM; Coggiano MA; Gleaves A; Slack RD; Zanettini C; Newman AH; Tanda G
    ACS Chem Neurosci; 2019 Apr; 10(4):2012-2021. PubMed ID: 30645944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An FSCV Study on the Effects of Targeted Typical and Atypical DAT Inhibition on Dopamine Dynamics in the Nucleus Accumbens Shell of Male and Female Mice.
    Hersey M; Chen AY; Bartole MK; Anand J; Newman AH; Tanda G
    ACS Chem Neurosci; 2023 Aug; 14(15):2802-2810. PubMed ID: 37466616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Sensitivity to Cocaine Self-Administration in HIV-1 Transgenic Rats is Associated with Changes in Striatal Dopamine Transporter Binding.
    McIntosh S; Sexton T; Pattison LP; Childers SR; Hemby SE
    J Neuroimmune Pharmacol; 2015 Sep; 10(3):493-505. PubMed ID: 25749646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual DAT and sigma receptor inhibitors attenuate cocaine effects on nucleus accumbens dopamine dynamics in rats.
    Hersey M; Mereu M; Jones CS; Bartole MK; Chen AY; Cao J; Hiranita T; Chun LE; Lopez JP; Katz JL; Newman AH; Tanda G
    Eur J Neurosci; 2024 May; 59(10):2436-2449. PubMed ID: 38444104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abstinence from chronic cocaine self-administration alters striatal dopamine systems in rhesus monkeys.
    Beveridge TJ; Smith HR; Nader MA; Porrino LJ
    Neuropsychopharmacology; 2009 Apr; 34(5):1162-71. PubMed ID: 18769473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reinforcing strength of a novel dopamine transporter ligand: pharmacodynamic and pharmacokinetic mechanisms.
    Woolverton WL; Ranaldi R; Wang Z; Ordway GA; Paul IA; Petukhov P; Kozikowski A
    J Pharmacol Exp Ther; 2002 Oct; 303(1):211-7. PubMed ID: 12235253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates.
    Gill KE; Pierre PJ; Daunais J; Bennett AJ; Martelle S; Gage HD; Swanson JM; Nader MA; Porrino LJ
    Neuropsychopharmacology; 2012 Nov; 37(12):2555-65. PubMed ID: 22805600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors.
    Hiranita T; Soto PL; Kohut SJ; Kopajtic T; Cao J; Newman AH; Tanda G; Katz JL
    J Pharmacol Exp Ther; 2011 Nov; 339(2):662-77. PubMed ID: 21859929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.